Clascoterone
Winlevi (clascoterone) is a small molecule pharmaceutical. Clascoterone was first approved as Winlevi on 2020-08-26. The pharmaceutical is active against androgen receptor. Winlevi's patents are valid until 2030-07-25 (FDA).
Trade Name | Winlevi |
---|---|
Common Name | Clascoterone |
Indication | |
Drug Class | Antiandrogens |